Cell death: Signaling and execution of apoptosis;Mort cellulaire: Signalisation et execution de l'apoptose

Hematologie

Volumn 5, Issue 5, 1999, Pages 376-387

  Ségal Bendirdjian, Évelyne ^a  

^a INSERM   (France)

Author keywords

Apoptosis; Bcl2; Cancer; Chemotherapy; Proteases

Indexed keywords

CASPASE; DNA; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEINASE;

APOPTOSIS; AUTOIMMUNITY; CANCER; CELL DEATH; DEGENERATIVE DISEASE; DNA DEGRADATION; ENZYME ACTIVITY; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032761499     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Kerr JFR, Wyllie AH, Currie AR Apoptosis : a basic biological phenomenon with wide ranging implications in tissue kinetics Br J Cancer 1972 ; 26 239-57.
2. Wyllie AH Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980 , 284 . 55-6
3. Savill J, Fadok V, Henson P, Haslett C Phagocyte recognition of cells undergoing apoptosis Immunol Today 1993 , 14 131-6
4. Ellis RE, Yuan JY, Horvitz HR Mechanisms and functions of cell death Annu Rev Cell Biol 1991 , 7 665-98
5. Tsujimoto Y, Ikegaki N, Croce CM Characterization of the protein product of bcl-2 the gene involved in human follicular lymphoma. Oncogene 1987 , 2 : 3-7
6. Askew DA, Ashmun RA, Simmonds BC, Cleveland JL Constitutive c-myc and IL-3 dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis Oncogene 1991 , 6 1915-22
7. Wang Y, Ramquist T, Szekely L, Axelson H, Klein G, Wiman KG. Reconstitution of wild type p53 expression triggers apoptosis in a p53 negative c-myc retrovirus-induced T-cell lymphoma line Cell Growth Diff 1993 , 4 467-73
8. Hickman JA Apoptosis induced by anticancer drugs Cancer Metas Rev 1992 , 11 : 121-39.
9. Thompson CB Apoptosis in the pathogenesis and treatment of disease. Science 1995 , 267 1456-62.
10. Quillet-Mary A, Mansat V, Duchayne E, Côme MG, Allouche M, Bailly JD, Bordier C, Laurent G Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cells Leukemia 1995 , 10 417-25
11. Nicholson DN, Thornberry NA Caspases the killer proteases Trends Biochem Sci 1997 , 22 299-306
12. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992 ; 80 879-86
13. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X Apaf-1, a human protein homologous to C elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997 , 90 : 405-13
14. Yuan J, Shaham S, Ledoux S, Ellis H, Horvitz HR The C elegans death ced-3 encodes a protein similar to mammalian interleukine-1 beta-converting enzyme Cell 1993 ; 75 641-52.
15. Martins LM, Kottke TJ, Mesner P, Basi GS, Sinha S, Frigon N Jr, Tatar E, Tung JS, Bryant K, Takahashi A, Svingen PA, Madden BJ, Mc Cormick DJ, Earnshaw WC, Kaufmann SH Activation of multiple interleukin-1β converting enzyme homologues in cytosol and nuclei of HL-60 human leukemia cell lines during etoposide-induced apoptosis. J Biol Chem 1997 , 272 7421-30
16. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P, Flavell RA Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996 , 384 368-72.
17. Yasuhara N, Eguchi Y, Tachibana T, Imamoto N, Yoneda Y, Tsujimoto Y Essential role of active nuclear transport in apoptosis. Genes Cells 1997 ; 2 : 55-64
18. Samejima K, Toné S, Kottke TJ, Enari M, Sakahira H, Cooke CA, Durrieu F, Marlins LM, Nagata S, Kaufmann SH, Earnshaw WC Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic execution J Cell Biol 1998 , 143 : 225-39.
19. Boise LH, Thompson CB Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation Proc Natl Acad Sci USA 1997 ; 94 3759-64.
20. McCarthy NJ, Whyte MK, Gilbert CS, Evan GI Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes DNA damage, or the Bcl-2 homologue Bak J Cell Biol 1997 ; 136 : 215-27
21. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14, 18) chromosome translocation Science 1984 , 226 1097-9
22. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog Bax, that accelerates programmed cell death Cell 1993 , 74 609-19
23. 2 targets the protein kinase Raf 1 to mitochondria Cell 1996 ; 87 : 629-38
24. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC Investigation of the subcellular distribution of the bcl-2 oncoprotein residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondria membranes. Cancer Res 1993 , 43 4701-14
25. Schendel SL, Xie ZH, Montal MO, Matsuyama S, Montal M, Reed JC Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci USA 1997 , 94 . 5113-8
26. 2 and impedes cell cycle progression at G2/M. Mol Cell Biol 1996 , 16 : 3884-91
27. Chinnaiyan AD, O'Rourke K, Lane BR, Dixit VM Interaction of CED-4 with CED-3 and CED-9 a molecular framework for cell death Science 1997 , 275 1122-6
28. Bissonnette RP, Echeverri E, Mahboubi A, Green DR Apoptotic cell death induced by c-myc is inhibited by bcl-2 Nature 1992 ; 359 552-4
29. Nakayama K, Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY Targeted disruption of Bcl-2 alpha beta in mice occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 1994 ; 91 . 3700-4
30. Wolvetang EJ, Johnson KL, Kraiuer K, Ralph SJ, Linnane AW Mitochondrial respiratory chain inhibitors induce apoptosis FEBS Lett 1994 , 339 40-4
31. Zamzani N, Marchetti P, Castedo M, Zanin C, Vayssière JL, Petit PX, Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995 ; 181 1661-72
32. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts requirement for dATP and cytochrome c. Cell 1996 , 86 : 147-57.
33. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P, Flavell RA. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9 Cell 1998 , 94 325-37
34. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J Peg TL, Jones DP, Wang X. Prevention of apoptosis by Bcl-2 release of cytochrome c from mitochondria blocked Science 1997 ; 275 1129-32
35. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick Conversion of Bcl-2 to a Bax-like death effector by caspases Science 1997 , 278 1966-8
36. Rosse T, Olivia R, Monney L, Rager M, Conus S, Fellay L, Jansen B, Borner C Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c Nature 1998 ; 391 496-9
37. Ficunane DM, Bossy-Weizel E, Waterhouse NJ, Cotter TG, Green DR Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J Biol Chem 1999 , 274 225-33
38. Arends MJ, Morris RG Wyllie AH Apoptosis . the role of the endonuclease Am J Pathol 1990 ; 136 : 593-608
39. Peitsch MC, Mannherz HG, Tschopp J. The apoptosis endonucleases cleaning up after death ? Trends Cell Biol 1994 , 4 . 37-41
40. Ségal-Bendirdjian E, Jacquemin-Sablon A Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process Exp Cell Res 1995 , 218 201-12
41. Enari M, Sakahiera H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD Nature 1998 , 391 43-50
42. Williams GT, Smith SA, Spooner E, Dexter TM, Taylor DR Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis Nature 1990 , 343 : 76-9.
43. Nagata S, Golstein P The Fas death factor. Science 1995 , 267 1449-56
44. Itoh N, Nagata S A novel protein domain required for apoptosis mutational analysis of human has antigen J Biochem Chem 1993 , 268 10932-7
45. Hsu H, Xiong J, Goeddel DV The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation Cell 1995 , 81 495-504
46. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis Cell 1995 , 81 505-12
47. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV. TNF-dependent recruitment of then protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996 , 4 : 387-96.
48. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruted to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 1996 , 85 : 817-27
49. Tracey KJ, Cerami A Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993 , 9 317-43
50. Friesen C, Herr I, Krammer PH, Debatin KM Involvement of CD95(Apo-1/Fas) receptor/ligand system in drug induced apoptosis in leukemia cells Nat Med 1996 , 2 . 574-7
51. Strand S, Hofman WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR Lymphocyte apoptosis induced by CD95(APO-1/Fas) ligand-expressing tumor cells A mechanism of immune evasion 2 Nature Med 1996 , 2 1361-6
52. Frankfurt OS, Seckinger D, Sugarber EV. Pleotropic drug resistance and survival advantage in leukemic cells with diminished apoptotic response. Int J Cancer 1994 , 59 217-24